Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia
- PMID: 16874169
- DOI: 10.1097/01.inf.0000226839.30925.a5
Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia
Abstract
Background: The incidence of community-acquired bacteremia (CAB) in Africa is several-fold higher than in industrialized countries. We report here the incidence of invasive bacterial infections in rural Gambia and compare the clinical characteristics of children with pneumococcal infection with those of children with extraintestinal nontyphoidal salmonella infection (NTS) or other bacterial infections.
Methods: As part of a pneumococcal conjugate vaccine trial, we investigated children aged 2-29 months who presented with signs suggestive of invasive bacterial infections.
Results: The incidence of invasive bacterial infections in all subjects was 1009 (95% CI, 903-1124) cases per 100,000 person-years. It was 1108 (95% CI, 953-1282) among children who had not received pneumococcal conjugate vaccine. Incidence decreased with increasing age but remained relatively high in 24- to 29-month-olds for pneumococcal infections. Pneumococcal infection was more frequent than NTS infections in the hot dry season. Respiratory symptoms and signs, consolidation on chest radiograph, and a primary diagnosis of pneumonia were more frequent in children with pneumococcal infection than in those with NTS or other infections. Diarrhea, laboratory evidence of malaria infection, and a primary diagnosis of malaria were more common in children with NTS infections.
Conclusions: Bacterial infections continue to cause significant morbidity in rural Africa. Although vaccines could greatly reduce the pneumococcal burden, a high index of suspicion and appropriate use of antimicrobials are needed to manage other causes of invasive bacterial infections.
Similar articles
-
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46. doi: 10.1016/S0140-6736(05)71876-6. Lancet. 2005. PMID: 15794968 Clinical Trial.
-
Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia.Pediatr Infect Dis J. 1998 Jan;17(1):23-8. doi: 10.1097/00006454-199801000-00006. Pediatr Infect Dis J. 1998. PMID: 9469390
-
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance.Lancet Infect Dis. 2021 Sep;21(9):1293-1302. doi: 10.1016/S1473-3099(20)30880-X. Epub 2021 Jul 21. Lancet Infect Dis. 2021. PMID: 34280357 Free PMC article.
-
Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. BMC Infect Dis. 2012. PMID: 22954038 Free PMC article. Review.
-
The potential of pneumococcal conjugate vaccines for children.Pediatr Infect Dis J. 2002 Oct;21(10):961-70. doi: 10.1097/00006454-200210000-00016. Pediatr Infect Dis J. 2002. PMID: 12394822 Review.
Cited by
-
Vaccination against pneumococcus in West Africa: perspectives and prospects.Int J Gen Med. 2013 Sep 11;6:757-64. doi: 10.2147/IJGM.S45842. eCollection 2013. Int J Gen Med. 2013. PMID: 24049454 Free PMC article.
-
Characterizing Pediatric Non-Malarial Fever and Identifying the At-Risk Child in Rural Malawi.Glob Pediatr Health. 2018 Jan 16;5:2333794X17750415. doi: 10.1177/2333794X17750415. eCollection 2018. Glob Pediatr Health. 2018. PMID: 29372177 Free PMC article.
-
A Prospective Study of Etiological Agents Among Febrile Patients in Sierra Leone.Infect Dis Ther. 2021 Sep;10(3):1645-1664. doi: 10.1007/s40121-021-00474-y. Epub 2021 Jun 26. Infect Dis Ther. 2021. PMID: 34173960 Free PMC article.
-
Invasive Nontyphoidal Salmonella Infections Among Children in Mali, 2002-2014: Microbiological and Epidemiologic Features Guide Vaccine Development.Clin Infect Dis. 2015 Nov 1;61 Suppl 4(Suppl 4):S332-8. doi: 10.1093/cid/civ729. Clin Infect Dis. 2015. PMID: 26449949 Free PMC article. Review.
-
Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine.BMC Infect Dis. 2008 Jun 11;8:81. doi: 10.1186/1471-2334-8-81. BMC Infect Dis. 2008. PMID: 18547404 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials